179 related articles for article (PubMed ID: 16787167)
1. Cytokines as targets in chronic obstructive pulmonary disease.
Chung KF
Curr Drug Targets; 2006 Jun; 7(6):675-81. PubMed ID: 16787167
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mediators in chronic obstructive pulmonary disease.
Chung KF
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):619-25. PubMed ID: 17305518
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
Knobloch J; Hag H; Jungck D; Urban K; Koch A
Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
[TBL] [Abstract][Full Text] [Related]
5. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
6. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
[TBL] [Abstract][Full Text] [Related]
7. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
8. Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.
Kim V; Cornwell WD; Oros M; Durra H; Criner GJ; Rogers TJ
BMC Pulm Med; 2015 Sep; 15():111. PubMed ID: 26424214
[TBL] [Abstract][Full Text] [Related]
9. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
10. Bronchial epithelium as a target for innovative treatments in asthma.
Gras D; Chanez P; Vachier I; Petit A; Bourdin A
Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
[TBL] [Abstract][Full Text] [Related]
11. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease.
Murugan V; Peck MJ
Exp Lung Res; 2009 Aug; 35(6):439-85. PubMed ID: 19842832
[TBL] [Abstract][Full Text] [Related]
13. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
[TBL] [Abstract][Full Text] [Related]
14. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
[TBL] [Abstract][Full Text] [Related]
15. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD.
Cosío BG; Jahn A; Iglesias A; Shafiek H; Busquets X; Agustí A
BMC Pulm Med; 2015 Dec; 15():157. PubMed ID: 26642881
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of statins: potential utility in COPD.
Young RP; Hopkins R; Eaton TE
Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.
Gupta V; Banyard A; Mullan A; Sriskantharajah S; Southworth T; Singh D
Br J Clin Pharmacol; 2015 May; 79(5):767-76. PubMed ID: 25377849
[TBL] [Abstract][Full Text] [Related]
20. Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.
Provost KA; Smith M; Arold SP; Hava DL; Sethi S
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):728-37. PubMed ID: 25338285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
